The rationale for this observatory is to evaluate clinical outcomes and collect data of the Polymer Free Sirolimus Eluting Coronary Stent System in Real World CAD Patients with follow-up at 12 months. All medications and procedures to be used/ performed in this observatory are commonly used/performed for clinical indications as part of standard of care and have well-defined safety profiles.

Inclusion Criteria:

• ≥18 years old
• Ability to provide signed informed consent form.
• Male or non-pregnant female patient (Pregnancy status to be confirmed verbally from the female patient of reproductive age)
• Presentation with acute coronary syndrome or chronic coronary syndrome with stable angina or angina equivalent symptoms or with a positive noninvasive test for ischemia or evidence of a functionally significant coronary stenosis.
• Patient having social security number.
• Patient treated only with Vivo ISAR stent in case of single or multiple vessel stenting

Exclusion Criteria:

• Concurrent participation in another clinical trial.
• Having benefited from an angioplasty of ≤ 1 month with a stent other than Vivo ISAR.
• Planned elective surgery in next 6 months
• Cardiogenic shock/ hemodynamically unstable patients
• Concurrent medical condition with a life expectancy of less than 12 months
• History of cerebrovascular accident in the last 6 months.
• Vulnerable patient under guardianship or curatorship

all-comers population who qualify for percutaneous coronary intervention (consisting of patients with symptomatic coronary artery disease including chronic coronary syndromes (CCS) and ACS) of any gender, ≥ 18 years old